ADMA

ADMA Biologics Inc

5.50 USD
-0.02 (-0.36%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ADMA Biologics Inc stock is up 5.16% since 30 days ago. The next earnings date is May 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.55% of the previous 10 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 20:02 17 May, 2024 2.50 CALL 100 182
31 Jan 18:17 16 Feb, 2024 5.00 CALL 770 3762

About ADMA Biologics Inc

ADMA Biologics, Inc. engages in developing, manufacturing, and marketing specialty plasma-derived biologics. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI) and ASCENIV. Nabi-HB for the. treatment of acute exposure to blood containing Hepatitis B surface antigen.

  • Cantor Fitzgerald
    Thu Feb 29, 13:49
    buy
    confirm
  • HC Wainwright & Co.
    Thu Feb 29, 09:04
    buy
    confirm